![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Grifols Earns CE Marks for HIV/Hepatitis and Babesia Parasite Blood Tests
Grifols Earns CE Marks for HIV/Hepatitis and Babesia Parasite Blood Tests
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
March 29, 2021
Grifols has received CE mark certifications for its Procleix UltrioPlex E and Procleix Babesia assays.
The Procleix UltrioPlex E, a nucleic acid test, uses a single sample of serum or plasma to simultaneously detect the presence of HIV-1, HIV-2, hepatitis B, hepatitis C and hepatitis E. The Procleix Babesia Assay detects Babesia, a tick-borne parasite that can be spread through blood transfusions, using a whole blood specimen.
The tests will soon become available in European markets, enabling blood banks to improve the safety of transfusions, the company said.
Upcoming Events
-
21Oct